Pharma

Pharma

AI holds potential to help identify and manage atopic dermatitis, says GlobalData

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation. As diagnosis of AD is primarily clinical, it may be subjective, resulting in variability […]

Pharma

Indian pharma companies focus on innovative research in foreign countries through dedicated entities, says GlobalData

Indian pharma players have increased their focus on innovative research and development (R&D). Historically, the majority of Indian companies used to execute their innovative research and development (R&D) from India. However, Indian companies have started establishing dedicated research companies in Western countries as well. Against this backdrop, the success of these dedicated research companies will […]

Pharma

AD 12-month diagnosed prevalent cases to reach 42.42 million in 7MM by 2033, forecasts GlobalData

The burden of 12-month diagnosed prevalent cases of atopic dermatitis (AD) is forecast to increase at an annual growth rate (AGR) of 0.10% from around 42.02 million cases in 2023 to 42.42 million cases in 2033 in the seven major markets (7MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Atopic […]

Pharma

AbbVie’s tavapadon holds potential to become prominent treatment in dopamine agonist market, says GlobalData

AbbVie recently announced positive topline results from its pivotal Phase III TEMPO-2 trial evaluating investigational tavapadon as a flexible-dose monotherapy in early Parkinson’s disease (PD). Tavapadon, the first and only D1/D5 partial agonist in the dopamine agonist class, is under investigation as a once-daily treatment for PD. The trial met both its primary and secondary […]

Pharma

First blood-stage vaccine shows promise for rising malaria cases, says GlobalData

A recent study carried out by researchers in Burkina Faso and the UK, and published in The Lancet Infectious Diseases, has shown that the first blood-stage malaria vaccine, RH5.1/Matrix-M, is safe, effective, and highly immunogenic. This double-blind, randomized, controlled, phase 2b trial, which analyzed 361 children between the ages of 5 and 17 months, shows […]

Pharma

DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space, says GlobalData

Mesoblast recently announced positive Phase III trial results in the European Journal of heart failure. The use of Revascor (rexlemestrocel-L) improved survival and reduced major morbidity in high-risk patients with ischemic heart failure (HF) and inflammation. This study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for […]

Pharma

12-month diagnosed prevalent cases of severe asthma across 8MM to reach 1.89 million in 2033, forecasts GlobalData

The 12-month diagnosed prevalent cases of severe asthma in the eight major markets (8MM*) are projected to increase at an annual growth rate (AGR) of 0.49% from 1.81 million in 2023 to 1.89 million in 2033, forecasts GlobalData, a leading data and analytics company. The lifetime diagnosed prevalent cases of severe asthma are also projected […]

Pharma

Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData

South Korea has emerged as a global leader in the biopharmaceutical industry, driven by its advanced clinical research infrastructure and government support. Key companies like Celltrion and Samsung Bioepis dominate the biosimilars market, contributing significantly to the approvals and pipelines. Celltrion’s strong presence in deal-making further underscores South Korea’s growing influence in the global biosimilars […]

Pharma

Unmet needs in chronic hand eczema present clear demand for new treatments, says GlobalData

Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterized by redness and itching, significantly reducing quality of life (QoL). Although multiple treatments for CHE are available, significant unmet need remains in long-term disease management and symptom control unable to be addressed by the current therapies. Therefore, there is a clear demand for therapies […]

Pharma

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

The schizophrenia market across the seven major markets (7MM*) is poised to grow at a compound annual growth rate (CAGR) of 7.4% from $8.4 billion in 2021 to $17.0 billion in 2031, driven by the anticipated introduction of 11 late-stage pipeline products during the forecast period, according to GlobalData, a leading data and analytics company. […]

Pharma

Toripalimab to fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in India, says GlobalData

Dr. Reddy’s Laboratories has recently become the first Indian company to launch checkpoint inhibitor Zytorvi (toripalimab) in collaboration with Shanghai Junshi Biosciences. Zytorvi is a pioneering immuno-oncology therapy for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). This marks a transformative moment, bringing a next-generation PD-1 inhibitor to India and addressing significant unmet medical needs. With the […]

Pharma

Respiratory syncytial virus prophylactic market to surpass $6 billion across 8MM in 2030, forecasts GlobalData

The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM*) is forecast to grow at a compound annual growth rate (CAGR) of 26.7% from $582 million in 2020 to $6.2 billion in 2030, with the pediatric and adult segments accounting for $2.2 billion and $4.0 billion, respectively, according to GlobalData, a leading […]

Pharma

Cobenfy set to break dopamine dominance in schizophrenia treatment, says GlobalData

The FDA has recently approved Karuna/Bristol Myers Squibb’s KarXT (Cobenfy), an oral medication for the treatment of schizophrenia in adults. Diverging from the traditional dopamine-based therapies, Cobenfy is said to address the critical gaps in the current treatments by targeting muscarinic acetylcholine receptors. Its success can pave the way for broader adoption of non-dopaminergic approaches […]

Pharma

One third of HCPs prioritize data privacy as the top challenge for AI in clinical practice, says GlobalData

The adoption of artificial intelligence (AI) in clinical practice is revolutionizing healthcare by improving efficiency and patient outcomes. However, with one-third of healthcare professionals identifying data privacy as the top challenge, addressing critical issues such as robust safeguards, workflow integration, and stakeholder acceptance is essential to ensure AI’s ethical implementation and long-term success, says GlobalData, […]

Pharma

Race for approval of first oral GLP-1R drug in obesity intensifies with four in phase III trials, says GlobalData

In recent years, GLP-1 receptor (GLP-1R) products have gained immense popularity. Currently, four innovative GLP-1Rs are approved worldwide for obesity, all of which are injectables. This leaves a gap in the obesity market for an oral GLP-1R product. 63 drugs are in active development, with four Phase III products racing to earn the inaugural approval […]

Pharma

NAPCHD’s new guidelines signal shift in type 1 diabetes management for care home residents in UK, says GlobalData

The National Advisory Panel on Care Home Guidance (NAPCHD) has introduced a groundbreaking framework designed to transform type 1 diabetes management in care homes across England. The comprehensive guidance, “Type 1 Diabetes in Care Homes: A Practical Guide on Management,” is aimed at addressing critical challenges in managing diabetes among care home residents. By offering […]

Pharma

Men’s Health Awareness Month highlights need for early prostate cancer detection, says GlobalData

The month of November is dedicated to raising awareness regarding pertinent health issues affecting men such as mental health and suicide prevention, prostate cancer, and testicular cancer. Prostate cancer is the fourth most common cancer worldwide and the second most common cancer in men after skin cancer, according to the World Cancer Research Fund International. […]

Pharma

AstraZeneca’s AZD4041 failure major blow for non-opioid medications treating opioid addiction, says GlobalData

Opioid use disorder (OUD) is a chronic neurological disorder characterized by the compulsive, repeated use of opioid drugs, leading to prolonged self-administration. AstraZeneca recently terminated the development of an OUD drug, AZD4041, after the orexin 1 receptor antagonist demonstrated a drug-drug interaction with an antifungal during a Phase II trial. The failure of the trial […]

Pharma

Biologic therapies mark progress in severe asthma treatment and remission potential, says GlobalData

Biologic therapies are revolutionizing severe asthma management by targeting specific inflammatory pathways, shifting care from symptom control to potential remission. Real-world evidence underscores their efficacy across diverse patient profiles, including those with complex asthma cases. However, barriers such as cost and accessibility persist, highlighting the urgent need for equitable healthcare solutions to ensure widespread adoption […]

Pharma

Pharma dose CMOs face growth slowdown, but opportunities lie ahead, says GlobalData

Contract manufacturing revenues in the pharmaceutical finished dose sector witnessed a significant slowdown over the past financial year. Challenging market conditions, driven by drug pricing pressures, regulatory shifts, and geopolitical tensions, have reshaped the landscape, offering both hurdles and opportunities for contract manufacturing organizations (CMOs) to adapt and innovate amidst global generic shortages, reveals GlobalData, […]

Prev 1 … 13 14 15 16 17 … 110 Next

AI holds potential to help identify and manage atopic dermatitis, says GlobalData

Indian pharma companies focus on innovative research in foreign countries through dedicated entities, says GlobalData

AD 12-month diagnosed prevalent cases to reach 42.42 million in 7MM by 2033, forecasts GlobalData

AbbVie’s tavapadon holds potential to become prominent treatment in dopamine agonist market, says GlobalData

First blood-stage vaccine shows promise for rising malaria cases, says GlobalData

DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space, says GlobalData

12-month diagnosed prevalent cases of severe asthma across 8MM to reach 1.89 million in 2033, forecasts GlobalData

Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData

Unmet needs in chronic hand eczema present clear demand for new treatments, says GlobalData

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

Toripalimab to fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in India, says GlobalData

Respiratory syncytial virus prophylactic market to surpass $6 billion across 8MM in 2030, forecasts GlobalData

Cobenfy set to break dopamine dominance in schizophrenia treatment, says GlobalData

One third of HCPs prioritize data privacy as the top challenge for AI in clinical practice, says GlobalData

Race for approval of first oral GLP-1R drug in obesity intensifies with four in phase III trials, says GlobalData

NAPCHD’s new guidelines signal shift in type 1 diabetes management for care home residents in UK, says GlobalData

Men’s Health Awareness Month highlights need for early prostate cancer detection, says GlobalData

AstraZeneca’s AZD4041 failure major blow for non-opioid medications treating opioid addiction, says GlobalData

Biologic therapies mark progress in severe asthma treatment and remission potential, says GlobalData

Pharma dose CMOs face growth slowdown, but opportunities lie ahead, says GlobalData

Browse

Company information